title: Buccal prochlorperazine causing perioral fixed drug eruption.
authors.forename: G
authors.initials: G
authors.lastname: Wylie
authors.forename: A
authors.initials: A
authors.lastname: Makrygeorgou
authors.forename: A D
authors.initials: AD
authors.lastname: Burden
mesh_terms: D000278:Administration, Buccal; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000382:microbiology; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000382:microbiology; D006801:Humans; D008297:Male; D011346:Prochlorperazine / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000150:complications; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D018492:Dopamine Antagonists; D011346:Prochlorperazine